Evidence map›Paper›PMID 42802758›Full record

ArticleClinical, cosmetic and investigational dermatology2026

Myxoid Onychomatricoma with Unusual CD99 Expression: A Report of a Rare Case and Literature Review.

Xingwei Zou, Zhongping Tang, Xueyu Zhang, Yongqiong Deng

Abstract readCase Reports
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xingwei ZouDepartment of Dermatology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Zhongping TangDepartment of Pathology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610041, People's Republic of China.
Xueyu ZhangDepartment of Dermatology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.
Yongqiong DengDepartment of Dermatology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, 610041, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onychomatricoma (OM) is a rare, benign fibroepithelial tumor originating from the nail matrix, with different clinical and histological variants documented in existing studies. Myxoid OM is an even rarer subtype, characterized by a prominent fibromyxoid component in histopathology. We report a case of a 34-year-old male patient presenting with clinical manifestations consistent with typical OM. Histopathological examination revealed a biphasic tumor composed of an epithelial component and a prominent myxoid stroma, suggesting a diagnosis of myxoid OM. Notably, the tumor exhibited diffuse CD99 positivity, an extremely rare finding in OM. Histopathologically, myxoid OM shows considerable morphological overlap with superficial acral fibromyxoma (SAFM). Our case illustrates that CD99 positivity cannot serve as an absolute criterion to exclude OM; cautious interpretation of this marker is required to avoid diagnostic pitfalls in the differential diagnosis of these two entities. This case expands the immunophenotypic spectrum of myxoid OM and offers a valuable reference for its differential diagnosis. Furthermore, we include and provide a descriptive review to summarize the clinicopathological features and key differential diagnostic considerations of OM, with a focus on diagnostic pitfalls arising from rare histological variants and atypical immunophenotypes, to facilitate accurate differential diagnosis of subungual tumors.

Indexed as

CD99immunohistochemistrymyxoid onychomatricomaonychomatricomasuperficial acral fibromyxoma

Identifiers

PMID42802758
PMCPMC13616141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.